Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Why Roth Capital Partners gives GameSquare a 'buy' rating

(Source: Roth Capital Partners) Click here to download Roth Capital Partners’ full report on GameSquare Holdings . This is third-party provided content issued on behalf of GameSquare Holdings Inc. (NDAQ:GAME) , please see full discl...

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...

U.S. Energy Firm's Stock at 'Good Entry Point,' Rating Upgraded to Outperform

An update on this company's valuation is provided in a Raymond James report. In an Aug. 13 research note, analyst Pavel Molchanov reported that Raymond James boosted its rating on Chart Industries Inc. (GTLS:NASDAQ) to Outperform from Market Perform, "...

Correction in Digital Marketing Sector Valuations Creates an Attractive Entry Point for Long-term In

(Click to read report.) Research Capital Corp. is – Initiating Coverage with a BUY Rating and Target Price of $2.20 (USD) on Logiq Inc. ( NEO: LGIQ , OTCQX: LGIQ , Forum ) Logiq’s Presence in Two Large and Growing Segments of Digital Marketing ...

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...

Rating, Target Upgraded on Gold Mining Major Undergoing a Turnaround

The reasons to be optimistic about this company are covered in a BMO Capital Markets report. In a Sept. 11 research note, analyst Andrew Kaip reported that his firm BMO Capital Markets upgraded its rating to Outperform and raised its target price to $50 per share from...

EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts

Analysts' reports on listed companies serve investors as an external source of information. As a rule, research houses publish their recommendations in connection with financing, the publication of financial statements or in order to increase awareness. The information is usua...

Coverage Initiated on 'Unique Silver Exploration Story'

The rationale for investing in this Canadian mining company is given in this BMO Capital Markets report. Silver Sand In an Aug. 13 research note, analyst Ryan Thompson reported that BMO Capital Markets initiated coverage on New Pacific Metals Corp. ...

RCC picks this Canadian small-cap tech stock for its organic growth

Research Capital Corp. is partnering with Stockhouse for a new video series highlighting and profiling compelling high-growth, small-cap companies in the Canadian market that hold strong buy recommendations from RCC analysts. Check out the first video above where Jam...

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
1 2 3 4 5 6 7 8 9 10 ...